It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

AI-derived predictive biomarker identifies two thirds of patients with high-risk prostate cancer who may benefit from ...

Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program ...

People live on average a little over two years after an mCRPC diagnosis. Find statistics here and learn how treatment ...

It used to be that radiation therapy for prostate cancer involved weeks or months of repeat visits to a clinic for treatment.

Scientists at the University of Michigan Rogel Cancer Center have found a promising new way to fight one of the most ...

Discover the role of commensal bacteria in the progression of prostate cancer and the potential treatment impacts.

Prostate cancer remains one of the most significant health concerns for men worldwide, with detection and treatment options ...

Using advanced imaging technologies as a means to enhance diagnostic accuracy was also of interest. Many HCPs pointed to the ...

Sophia Kamran, MD, discusses how salvage therapy after biochemical recurrence may improve outcomes for patients with prostate ...

Women who incorporated testosterone into their hormone replacement therapy regimen through bioidentical ... Alzheimer's disease, prostate cancer, and more. Experience the power of hormone ...